Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
RBI accepts lower bond purchase amount in first FY26 OMO auction
20/05/2025
Protean eGov Technologies shares plunge 20% after downgrade amid PAN 2.0 project withdrawal
20/05/2025
How will Resonac's plant closures impact the global graphite market ?
20/05/2025
RBI okays Emirates NBD Bank PJSC's subsidiary plan in India
19/05/2025
DRL gears up for biosimilar push, consumer health growth post record FY25
19/05/2025
The UK and the EU announce new deals and renew ties, 5 years after Brexit
19/05/2025
